1 TGF-p TYPE II RECEPTOR CDNAS This application is a division of co-pending application Ser. No. 08/311703 filed Sep. 23, 1994, which is a File Wrapper ...

[0003] WO2005011646 describes angiotensin II receptor blocker nitroderivatives, pharmaceutical compositions containing them and their use for the treatment ...

[0046] The present invention provides in vivo methods for identifying compounds that increase or decrease the biological activity of an U-II receptor.

166 Inhibition of Acetyl-cyclic[Cys-Phe-Trp-Lys-(2-Nal)-Cys]-NH2* induced Ca2+ mobilization (FLIPR) in CHO cells transfected with rat UII receptor ...

UROTENSIN II RECEPTOR ANTAGONISTS CROSS REFERENCE TO RELATED APPLICATIONS [0001] The present application is a divisional of US application Ser. No.

5 Surprisingly, binding of radio-labeled ligand to the type II receptor was increased by 2.5 fold in cells expressing the type III cDNA.

US005326776A [ii] Patent Number: 5326776 [45] Date of Patent: Jul. 5, 1994 [54] ANGIOTENSIN II RECEPTOR ANTAGONISTS [75] Inventors: Martin Winn, Deerfield, ...

(54) ANGIOTENSIN II RECEPTOR ANTAGONISTS Correspondence Address: COVINGTON & BURLING, LLP ATTN: PATENT DOCKETING 1201 PENNSYLVANIA AVENUE, NW WASHINGTON, ...